Scott Bruns and Kathleen Meriwether of Ernst & Young count down the top five compliance risks facing life sciences companies, including sales & marketing risks, the FCPA and IFRS, as well as supply-chain integrity and aggregate spend.
September 30, 2009
March 10, 2010
March 1, 2010
February 25, 2010
February 24, 2010
February 23, 2010
March 2, 2010
February 18, 2010
February 16, 2010
March 10, 2010
March 10, 2010
March 1, 2010
January 18, 2010
January 12, 2010
March 10, 2010
March 4, 2010
March 1, 2010
February 25, 2010
February 18, 2010
February 11, 2010
February 17, 2010
February 18, 2010
February 15, 2010
February 11, 2010
March 10, 2010
March 7, 2010
March 1, 2010
February 1, 2010
The "Massive News" theme by: Press75.com
|
Home |
About |
Contact |
Authors |
Write for CCI |
Article Guildelines |
Compliance News |
People on the Move |
Legal Notice |
Privacy Policy |
Corporate Compliance Insights is a professionally designed and managed forum dedicated to online discussion and analysis of corporate compliance and governance topics. Additionally, Corporate Compliance Insights is a focused knowledge-sharing forum designed to educate and encourage informed interaction within the corporate compliance community.
Helpful resources:
NCAA tournament schedule, March Madness 2010 tickets
